Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
【Health Gen Group Subsidiary, Craftsman Story】Health Gen: Technological Advancement Never Stops
Time Posted：2021-05-26 17:28
Initially, my understanding of craftsmen was that they were taciturn masters, wearing large glasses and leather aprons, working in a dimly lit workshop, performing the same task day in and day out for decades, like machines. However, after learning about the glorious deeds of national craftsmen such as Li Wanjun, an academician worker; Shi Pinfang, an expert in processing parts for domestically produced large aircraft; and Yu Shuangli, an electrician technician who enjoys special government allowances, my understanding of craftsmen has changed: New-era craftsmen should dedicate themselves to every task and constantly pursue technological breakthroughs.
Time Posted：2021-05-19 15:29
After more than 20 years of market trials, HealthGen has cultivated its own unique brand identity - craftsmanship + quality + sentiment. Guided by its mission of "For health, for tomorrow", the group has always adhered to quality, striving to create a healthy ecosystem community of shared destiny.
Time Posted：2021-05-10 14:09
Recently, HealthGen (600380.SH) announced that its wholly-owned subsidiary, Shenzhen Haibin Pharmaceutical Co., Ltd., received the Drug Registration Certificate for Alogliptin Benzoate Tablets from the National Medical Products Administration.
Time Posted：2021-04-21 16:07
On April 20, 2021, a donation ceremony for poverty alleviation and rural revitalization assistance for chronic diseases was held in the meeting room of the Huangshan District Health and Health Commission in Huangshan City, Anhui Province. Huangshan, Anhui received a donation of 1 million yuan worth of poverty alleviation medicines from Health Yuan & Lizhu Group. These medicines will be used to improve rural public service medical resources, focusing on supporting 800 registered impoverished households in communities around Jiulong Peak, covering 11 administrative villages around Jiulong Peak.
Hope for 'Life', Future for 'Growth' - Lizhu's Recombinant HCG Approved for Marketing
Time Posted：2021-04-16 18:41
On the evening of April 15, 2021, Zhuhai Lizhu Monoclonal Antibody Biotechnology Co., Ltd. received the "Drug Registration Certificate" issued by the National Medical Products Administration. Recombinant Human Chorionic Gonadotropin Injection (recombinant HCG) successfully passed the "Pharmaceutical Administration Law of the People's Republic of China" and relevant regulations, and was issued a drug registration certificate, allowing it to be produced and sold on the market.
Time Posted：2021-04-13 16:08
In recent years, the concept of "Made in China" has become popular, and raw materials for medicines, known as the "chips" of the pharmaceutical industry, are gradually becoming a new label for "Made in China" in the biopharmaceutical industry. After the stress test of the COVID-19 pandemic, the crucial industrial position of domestic raw materials for medicines has become even more prominent.
Enabling 160 million people to use domestically produced drugs, Health Spring awaits its voyage.
Time Posted：2021-04-12 17:19
Respiratory diseases are the third most common chronic disease in China, after cardiovascular and diabetic diseases, with more than 160 million patients. Less than 10% of patients in China receive standardized treatment (expected total), and the number of patients is severely underestimated. Academician Wang Chen's research shows that only 5.6% of asthma patients regularly use ICS.
Time Posted：2021-04-08 17:38
On April 3, Health Yuan's application for clinical trials of its innovative Class 2 drug, inhaled powder of arbidol ammonium, was accepted. Currently, there are no similar inhaled agents on the market. Earlier (March 2021), AstraZeneca submitted a Class 5.1 imported clinical application for arbidol ammonium powder inhaler, which is currently under review and approval. Whether the original research drug will be approved for import first or the domestic new drug will seize the opportunity is worth further attention.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.